The following are recent developments in Cell and Gene Therapy, from Volume 1, Issue 13 of Cell and Gene Therapy Business Outlook, published December 22, 2021 Arrowhead Pharmaceuticals, based in Pasadena, CA, has completed a purchase of 13 acres in the Verona Technology Park in Verona, WI, where it plans to invest between $200 million […]
Cell and Gene Therapy Business Outlook Editor Blake Middleton on Significant CGT Developments at Meeting on the Mesa The Meeting on the Mesa is going on. ( https://meetingonthemesa.com/agenda/) More than 1700 attendees are at the cell and gene therapy-focused meeting, along with Science Advisory Board, LabPulse and other members of the Science and Medicine group family. […]
Over 54 BN across funding mechanisms. Private, VC, SPAC and and IPO Over 20Billion The enormous amount of funding presages confidence in discoveries of future marketable products as well as platforms in cell and gene therapy. With an aggressive third quarter 2021 for funding, it is worthwhile to total and assess where we are. In […]
Cell and gene therapies are trending as groundbreaking treatments with the potential to actually cure disease rather than simply manage symptoms. As a result, through 2030, the global market for cell and gene therapy is forecast to expand strongly to $29,960 million, up from $3,866 million in 2020, according to a 2021 report by Kalorama […]
In this post, we update on and analyze some of the recent stories in the news regarding Cell and Gene Therapy. For detailed updates, additional news analysis, scientific innovations and market opportunity updates, subscribe to Cell and Gene Therapy Business Outlook from Science and Medicine Group. Avantor, based in Radnor, PA, has agreed to purchase […]
Learn more about this important market by subscribing to CELL AND GENE THERAPY BUSINESS OUTLOOK, a twice-monthly publication from the leaders at Kalorama Information. This is an exciting time for the cell and gene therapy industry. Its products are transforming the treatment of cancers and genetic diseases, as well as a host of other illnesses […]
Email Us: Customer Service
Phone (US): 703-778-3080
Fax: 703-778-3081
